Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis-Reference-Cited by-同舟云学术

Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis

Published:2005-06 Issue:11 Volume:21 Page:1331-1339
ISSN:0269-2813
Container-title:Alimentary Pharmacology and Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ohkusa T.,Maekawa T.,Arakawa T.,Nakajima M.,Fujimoto K.,Hoshino E.,Mitachi Y.,Hamada S.,Mine T.,Kawahara Y.,Nagai T.,Aoyama N.,Yoshida N.,Tadokoro K.,Chida N.,Konda Y.,Seno H.,Shimatani T.,Inoue M.,Sato N.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2005.02486.x/fullpdf

Reference20 articles.

1. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials

2. Long-term use of proton pump inhibitors in GORD - help or hindrance?

3. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: A prospective study

4. Safety Experience from Long-Term Treatment with Omeprazole

5. The Clinical Safety of Omeprazole

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Vonoprazan vs. Pantoprazole or Non-acid Suppression in Prevention of Post-variceal Ligation Ulcer Bleeding in Portal Hypertension: A Multi-arm Randomized Controlled Trial;Journal of Clinical and Experimental Hepatology;2023-11

2. A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lens;Expert Opinion on Drug Metabolism & Toxicology;2023-02-01

3. Propensity score matching analysis: incidence and risk factors for “stardust” gastric mucosa, a novel gastric finding potentially induced by vonoprazan;Alimentary Pharmacology & Therapeutics;2020-11-07

4. Pharmacogenomic considerations for medications in the perioperative setting;Pharmacogenomics;2019-07

5. Oral esomeprazole in Japanese pediatric patients with gastric acid-related disease: Safety, efficacy, and pharmacokinetics;Pediatrics International;2019-01